These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28058221)

  • 21. Non-invasive assessment of liver graft fibrosis by transient elastography after liver transplantation.
    Barrault C; Roudot-Thoraval F; Tran Van Nhieu J; Atanasiu C; Kluger MD; Medkour F; Douvin C; Mallat A; Zafrani ES; Cherqui D; Duvoux C
    Clin Res Hepatol Gastroenterol; 2013 Sep; 37(4):347-52. PubMed ID: 23318116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection.
    do O NT; Eurich D; Schmitz P; Schmeding M; Heidenhain C; Bahra M; Trautwein C; Neuhaus P; Neumann UP; Wasmuth HE
    Liver Transpl; 2012 Mar; 18(3):298-304. PubMed ID: 22139994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for allograft failure in liver transplant recipients.
    Huesing-Kabar A; Dohna CZ; Heinzow H; Cicinnati VR; Beckebaum S; Schmidt M; Gerth HU; Pohlen M; Wilms C; Palmes D; Schmidt HH; Kabar I
    Z Gastroenterol; 2018 Jul; 56(7):745-751. PubMed ID: 29341040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of hepatitis C virus-positive grafts in liver transplantation: a single-centre experience.
    Ricchiuti A; Brunati A; Mirabella S; Pierini A; Franchello A; Salizzoni M
    Transplant Proc; 2005; 37(6):2569-70. PubMed ID: 16182746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
    Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
    Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholestatic hepatitis C following liver transplantation: an outcome-based histological definition, clinical predictors, and prognosis.
    Verna EC; Abdelmessih R; Salomao MA; Lefkowitch J; Moreira RK; Brown RS
    Liver Transpl; 2013 Jan; 19(1):78-88. PubMed ID: 23081888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C.
    Machicao VI; Bonatti H; Krishna M; Aqel BA; Lukens FJ; Nguyen JH; Rosser BG; Satyanarayana R; Grewal HP; Hewitt WR; Harnois DM; Crook JE; Steers JL; Dickson RC
    Transplantation; 2004 Jan; 77(1):84-92. PubMed ID: 14724440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation.
    Toniutto P; Fabris C; Avellini C; Minisini R; Bitetto D; Rossi E; Smirne C; Pirisi M
    World J Gastroenterol; 2005 Oct; 11(38):5944-50. PubMed ID: 16273604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
    Yilmaz N; Shiffman ML; Stravitz RT; Sterling RK; Luketic VA; Sanyal AJ; Mills AS; Contos MJ; Coterell A; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
    Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
    Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of Poor Prognosis in Recurrent Hepatitis C After Liver Transplantation.
    Berge E; Otón E; Reina Z; Díaz L; Márquez A; Cejas L; Acosta S; Pérez F
    Transplant Proc; 2016 Nov; 48(9):2997-2999. PubMed ID: 27932129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of donor histology on survival following liver transplantation for chronic hepatitis C virus infection: a Scandinavian single-center experience.
    Ydreborg M; Westin J; Lagging M; Castedal M; Friman S
    Scand J Gastroenterol; 2012 Jun; 47(6):710-7. PubMed ID: 22452366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus.
    Mutimer DJ; Gunson B; Chen J; Berenguer J; Neuhaus P; Castaing D; Garcia-Valdecasas JC; Salizzoni M; Moreno GE; Mirza D
    Transplantation; 2006 Jan; 81(1):7-14. PubMed ID: 16421468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C.
    Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Reed A; Hemming A; Howard R; Van Der Werf W; Lauwers G; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2002 Nov; 8(11):1000-6. PubMed ID: 12424712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of liver transplantation from hepatitis B core antibody-positive donors in viral cirrhosis patients: the prevailing negative effect of recipient hepatitis C virus infection.
    Tandoi F; Romagnoli R; Martini S; Mazza E; Nada E; Cocchis D; Lupo F; Salizzoni M
    Transplant Proc; 2012 Sep; 44(7):1963-5. PubMed ID: 22974883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
    Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
    Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
    Tao R; Ruppert K; Cruz RJ; Malik SM; Shaikh O; Ahmad J; DiMartini A; Humar A; Fontes PA; de Vera ME
    Liver Transpl; 2010 Nov; 16(11):1288-95. PubMed ID: 21031544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, virological, and histologic evolution of hepatitis C virus infection in liver transplant recipients.
    Lumbreras C; Colina F; Loinaz C; Domingo MJ; Fuertes A; Dominguez P; Gómez R; Aguado JM; Lizasoain M; González-Pinto I; Garcia I; Moreno E; Noriega AR
    Clin Infect Dis; 1998 Jan; 26(1):48-55. PubMed ID: 9455508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients.
    Ferri F; Lai Q; Molinaro A; Poli E; Parlati L; Lattanzi B; Mennini G; Melandro F; Pugliese F; Maldarelli F; Corsi A; Riminucci M; Merli M; Rossi M; Ginanni Corradini S
    Can J Gastroenterol Hepatol; 2019; 2019():5862985. PubMed ID: 31187028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.